

Immunodiagnostic Systems Holdings PLC is part of the healthcare market. As a global medical device manufacturer, its business is to develop, manufacture and market innovative immunoassays and automated immunoanalyser technologies. The company manages its operations through two segments, The Systems unit, which markets its products to other businesses and the Biological unit, which licenses or sells antibodies to other companies.